NAYA Biosciences Inc
NAYA2.200USD
+0.210+10.34%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
8.59MMarket Cap
LossP/E TTM
NAYA Biosciences Inc
2.200
+0.210+10.34%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Total revenue
47.01%1.43M
481.38%1.84M
352.92%1.58M
396.78%1.38M
314.28%974.89K
116.17%315.90K
114.04%348.02K
--278.14K
--235.32K
--146.13K
--162.60K
Revenue
47.01%1.43M
481.38%1.84M
352.92%1.58M
396.78%1.38M
314.28%974.89K
116.17%315.90K
114.04%348.02K
--278.14K
--235.32K
--146.13K
--162.60K
Cost of revenue
102.66%1.22M
327.53%1.09M
1384.68%1.08M
1198.52%1.03M
123.84%601.47K
32.61%255.42K
11.69%72.55K
--79.19K
--268.71K
--192.61K
--64.96K
Operating expenses
46.87%2.73M
57.00%3.74M
-4.96%2.52M
-3.54%2.89M
-32.58%1.86M
-15.77%2.38M
-7.30%2.65M
--3.00M
--2.76M
--2.83M
--2.86M
R&D expenses
-100.00%0.00
-100.00%0.00
-93.36%4.88K
-92.00%5.91K
-98.48%2.67K
-56.04%83.85K
-29.43%73.52K
--73.83K
--175.27K
--190.76K
--104.18K
Depreciation, depletion, and amortization
1024.15%230.50K
1068.93%230.34K
1089.08%226.96K
610.12%141.60K
3.91%20.50K
-10.77%19.70K
22.77%19.09K
--19.94K
--19.73K
--22.08K
--15.55K
Other operating expenses
----
----
----
----
----
--1.00
----
----
----
----
----
Operating profit
-46.72%-1.30M
7.89%-1.90M
58.97%-946.37K
44.51%-1.51M
64.91%-886.29K
22.96%-2.07M
14.61%-2.31M
---2.72M
---2.53M
---2.68M
---2.70M
Net non-operating interest income (expenses)
Non-operating interest income
--0.00
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--1.00
--34.00
--48.00
--225.00
Non-operating interest expense
-22.28%273.63K
110.98%369.61K
-16.30%181.29K
224.35%182.04K
19893.47%352.08K
171656.86%175.19K
14775.62%216.59K
--56.13K
--1.76K
--102.00
--1.46K
Gains from sale of securities
----
----
100.00%0.00
99.26%-4.00
98.41%-16.00
70.16%-265.00
86.84%-135.00
---541.00
---1.01K
---888.00
---1.03K
Return on equity
-235.32%-27.37K
371.12%17.85K
100.37%104.00
-381.40%-28.16K
61.98%-8.16K
103.21%3.79K
61.00%-27.73K
--10.01K
---21.47K
---117.98K
---71.12K
Special income (expenses)
--0.00
---40.49K
--94.55K
---253.07K
----
----
----
--0.00
----
----
----
- Gains from disposal of fixed assets
--0.00
--50.00K
---561.66K
----
----
----
----
----
----
----
----
Income before tax
-28.47%-1.60M
-0.34%-2.25M
37.49%-1.59M
28.69%-1.97M
51.11%-1.25M
20.11%-2.24M
8.05%-2.55M
---2.76M
---2.55M
---2.80M
---2.77M
Income tax
1451.38%29.26K
-100.00%0.00
--1.84K
1011.73%23.04K
--1.89K
258.13%2.87K
----
--2.07K
--0.00
--800.00
----
Income after tax
-30.62%-1.63M
-0.21%-2.25M
37.41%-1.60M
27.91%-1.99M
51.03%-1.25M
20.03%-2.24M
8.05%-2.55M
---2.77M
---2.55M
---2.80M
---2.77M
Net income from continuous operations
-30.62%-1.63M
-0.21%-2.25M
37.41%-1.60M
27.91%-1.99M
51.03%-1.25M
20.03%-2.24M
8.05%-2.55M
---2.77M
---2.55M
---2.80M
---2.77M
Net income attributable to controlling interests
-30.62%-1.63M
-0.21%-2.25M
37.41%-1.60M
27.91%-1.99M
51.03%-1.25M
20.03%-2.24M
8.05%-2.55M
---2.77M
---2.55M
---2.80M
---2.77M
Net income attributable to common shareholders
-30.62%-1.63M
-0.21%-2.25M
37.41%-1.60M
27.91%-1.99M
51.03%-1.25M
20.03%-2.24M
8.05%-2.55M
---2.77M
---2.55M
---2.80M
---2.77M
Basic earnings per share
40.27%-0.42
98.98%-0.62
84.37%-0.64
71.99%-1.27
83.25%-0.70
-1223.18%-61.19
11.00%-4.10
---4.55
---4.19
---4.62
---4.60
Diluted earnings per share
40.27%-0.42
98.98%-0.62
84.37%-0.64
71.99%-1.27
83.25%-0.70
-1223.18%-61.19
11.00%-4.10
---4.55
---4.19
---4.62
---4.60
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
